Embla Medical hf (LTS:0FIW) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0FIW Embla Medical hf LTS:0FIW
81 GF Score
Price kr27.00
GF Value kr35.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0FIW
81GF Score
Embla Medical hf LTS:0FIW
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Embla Medical hf (LTS:0FIW) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of kr27.00 is trading 23.6% below its estimated GF Value™ of kr35.33. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for LTS:0FIW:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr35.33 vs. price of kr27.00 (23.6% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the LTS:0FIW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Other Exchanges EMBLA:Denmark5IQ:Germany
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
81GF Score

Get the complete analysis for LTS:0FIW

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr27.00
Price
kr35.33
GF Value